Terms: = Sarcomas AND NUP214, ENSG00000126883, 8021, MGC104525, D9S46E, RP11-544A12_7, N214, CAIN, P35658, CAN AND Clinical Outcome
225 results:
1. clinical outcome in Patients With High-grade Soft-tissue Sarcoma Receiving Prosthetic Replacement After Tumor Resection of the Lower Extremities: Tokai Musculoskeletal Oncology Consortium Study.
Nakamura T; Sakai T; Tsukushi S; Kimura H; Wasa J; Hosono K; Izubuchi Y; Kozawa E; Nagano A; Asanuma K; Sudo A; Nishida Y
In Vivo; 2023; 37(6):2642-2647. PubMed ID: 37905645
[TBL] [Abstract] [Full Text] [Related]
2. Identification of dual STRN-NTRK2 rearrangements in a high grade sarcoma, with good clinical response to first-line larotrectinib therapy.
Lin R; Mallick AB; Wang ZX; Brown SA; Lu B; Jiang W
Diagn Pathol; 2023 Oct; 18(1):116. PubMed ID: 37865792
[TBL] [Abstract] [Full Text] [Related]
3. REGISTRI: Regorafenib in first-line of KIT/PDGFRA wild type metastatic GIST: a collaborative Spanish (GEIS), Italian (ISG) and French Sarcoma Group (FSG) phase II trial.
Martin-Broto J; Valverde C; Hindi N; Vincenzi B; Martinez-Trufero J; Grignani G; Italiano A; Lavernia J; Vallejo A; Tos PD; Le Loarer F; Gonzalez-Campora R; Ramos R; Hernández-Jover D; Gutierrez A; Serrano C; Monteagudo M; Letón R; Robledo M; Moura DS; Martin-Ruiz M; López-Guerrero JA; Cruz J; Fernandez-Serra A; Blay JY; Fumagalli E; Martinez-Marin V
Mol Cancer; 2023 Aug; 22(1):127. PubMed ID: 37559050
[TBL] [Abstract] [Full Text] [Related]
4. clinical outcomes of Intensity-modulated Carbon-ion Radiotherapy for Bone and Soft Tissue Tumors.
Takakusagi Y; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Kamada T; Katoh H
Anticancer Res; 2023 Jun; 43(6):2777-2781. PubMed ID: 37247930
[TBL] [Abstract] [Full Text] [Related]
5. Type 2 Diabetes Mellitus and Efficacy outcomes from Immune Checkpoint Blockade in Patients with Cancer.
Cortellini A; D'Alessio A; Cleary S; Buti S; Bersanelli M; Bordi P; Tonini G; Vincenzi B; Tucci M; Russo A; Pantano F; Russano M; Stucci LS; Sergi MC; Falconi M; Zarzana MA; Santini D; Spagnolo F; Tanda ET; Rastelli F; Giorgi FC; Pergolesi F; Giusti R; Filetti M; Lo Bianco F; Marchetti P; Botticelli A; Gelibter A; Siringo M; Ferrari M; Marconcini R; Vitale MG; Nicolardi L; Chiari R; Ghidini M; Nigro O; Grossi F; De Tursi M; Di Marino P; Queirolo P; Bracarda S; Macrini S; Inno A; Zoratto F; Veltri E; Spoto C; Vitale MG; Cannita K; Gennari A; Morganstein DL; Mallardo D; Nibid L; Sabarese G; Brunetti L; Perrone G; Ascierto PA; Ficorella C; Pinato DJ
Clin Cancer Res; 2023 Jul; 29(14):2714-2724. PubMed ID: 37125965
[TBL] [Abstract] [Full Text] [Related]
6. Neurosurgical management of proton beam therapy-induced moyamoya syndrome.
Zhang CH; Muirhead W; Silva AHD; Toolis C; Robertson F; Rennie A; Bhate S; Thompson DNP; Ganesan V; James G
J Neurosurg Pediatr; 2023 Apr; 31(4):369-379. PubMed ID: 36738468
[TBL] [Abstract] [Full Text] [Related]
7. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
[TBL] [Abstract] [Full Text] [Related]
8. Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract] [Full Text] [Related]
9. clinical management of melanocytic tumours of uncertain malignant potential (MelTUMPs), including melanocytomas: A systematic review and meta-analysis.
Varey AHR; Williams GJ; Lo SN; Taing CY; Maurichi A; Santinami M; Scolyer RA; Thompson JF
J Eur Acad Dermatol Venereol; 2023 May; 37(5):859-870. PubMed ID: 36251355
[TBL] [Abstract] [Full Text] [Related]
10. Intercalary frozen autografts for reconstruction of bone defects following meta-/diaphyseal tumor resection at the extremities.
Yang J; Li W; Feng R; Li D
BMC Musculoskelet Disord; 2022 Sep; 23(1):890. PubMed ID: 36180843
[TBL] [Abstract] [Full Text] [Related]
11. Follicular dendritic cell sarcoma of gastrointestinal tract with two emerging distinct subtypes: a case report and systemic review.
Gui H; Chaudhari J; Mannan R
Diagn Pathol; 2022 Aug; 17(1):64. PubMed ID: 35941667
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of rare driving events in pediatric acute myeloid leukemia.
Noort S; Oosterwijk JV; Ma J; Garfinkle EAR; Nance S; Walsh M; Song G; Reinhardt D; Pigazzi M; Locatelli F; Hasle H; Abrahamsson J; Jarosova M; Kelaidi C; Polychronopoulou S; Van den Heuvel-Eibrink MM; Fornerod M; Gruber TA; Zwaan CM
Haematologica; 2023 Jan; 108(1):48-60. PubMed ID: 35899387
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcomes of Scanning Carbon-ion Radiotherapy for Soft Tissue Sarcoma of the Extremities.
Takakusagi Y; Serizawa I; Koge H; Kano K; Shima S; Tsuchida K; Mizoguchi N; Yoshida D; Katoh H; Hiruma T; Kamada T
Anticancer Res; 2022 Jul; 42(7):3701-3706. PubMed ID: 35790269
[TBL] [Abstract] [Full Text] [Related]
14. Thoracic Epithelioid Hemangioendothelioma: clinical demonstration and therapeutic procedures.
Graça LL; Almeida Cunha S; Lopes RS; Carvalho L; Prieto D
Port J Card Thorac Vasc Surg; 2022 Jul; 29(2):39-44. PubMed ID: 35780414
[TBL] [Abstract] [Full Text] [Related]
15. clinical outcome Following Prolonged Neoadjuvant Chemotherapy and Delayed Surgery in Osteosarcoma Patients: An Evidence-based clinical Review.
Sugito W; Kamal AF
Acta Med Indones; 2022 Jan; 54(1):142-150. PubMed ID: 35398837
[TBL] [Abstract] [Full Text] [Related]
16. Mesenchymal neoplasms of the parotid gland and parapharyngeal space: an FNA cytologic study of 22 nonlipomatous tumors.
Wakely PE
Cancer Cytopathol; 2022 Jun; 130(6):443-454. PubMed ID: 35195952
[TBL] [Abstract] [Full Text] [Related]
17. clinical outcome of paediatric ewing sarcoma and significance of pathological necrosis for mortality after neoadjuvant chemotherapy: Single institutional study.
Sindhu II; Mehreen A; Wali RM; Abubakar M
J Pak Med Assoc; 2021 Oct; 71(10):2344-2349. PubMed ID: 34974568
[TBL] [Abstract] [Full Text] [Related]
18. Dermatofibrosarcoma protuberans. A single center retrospective experience.
Guner M; Morkavuk SB; Unal AE
Ann Ital Chir; 2021; 92():539-544. PubMed ID: 34795112
[TBL] [Abstract] [Full Text] [Related]
19. clinical Activity of Single-Agent Cabozantinib (XL184), a Multi-receptor Tyrosine Kinase Inhibitor, in Patients with Refractory Soft-Tissue sarcomas.
O'Sullivan Coyne G; Kummar S; Hu J; Ganjoo K; Chow WA; Do KT; Zlott J; Bruns A; Rubinstein L; Foster JC; Juwara L; Meehan R; Piekarz R; Streicher H; Sharon E; Takebe N; Voth AR; Bottaro D; Costello R; Wright JJ; Doroshow JH; Chen AP
Clin Cancer Res; 2022 Jan; 28(2):279-288. PubMed ID: 34716194
[TBL] [Abstract] [Full Text] [Related]
20. Fusion of the Paired Box 3 (
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065
[TBL] [Abstract] [Full Text] [Related]
[Next]
